✦ LIBER ✦

Gemcitabine modulation of alkylator therapy : A Phase I trial of escalating gemcitabine added to fixed doses of ifosfamide and doxorubicin

✍ Scribed by Randall E. Millikan; William K. Plunkett; Terry L. Smith; Dallas L. Williams; Christopher J. Logothetis

Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 70 KB
Volume: 92
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(20010701)92:1<194::aid-cncr1309>3.0.co;2-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase I trial of fixed dose rate gemci

A Phase I trial of fixed dose rate gemcitabine and capecitabine in metastatic renal cell carcinoma

✍ Brian I. Rini; Vivian Weinberg; Eric J. Small 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 2 views

## Abstract ## BACKGROUND Metastatic renal cell carcinoma (RCC) has modest response rates to chemotherapy with gemcitabine and 5‐fluorouracil (5‐FU). Fixed dose rate gemcitabine infusion leads to enhanced intracellular accumulation of drug and possible augmented clinical effect. To determine the t

A Phase I–II trial of escalating doses o

A Phase I–II trial of escalating doses of mitoxantrone with fixed doses of cytarabine plus fludarabine as salvage therapy for patients with acute leukemia and the blastic phase of chronic myelogenous leukemia

✍ Charles A. Koller; Hagop M. Kantarjian; Eric J. Feldman; Susan O'Brien; Mary Bet 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 2 views

## BACKGROUND. Cytarabine is an essential drug for inducing remission of acute myelogenous leukemia, and it is also one the most effective drugs used as salvage therapy for patients with all types of relapsed acute leukemia. Nevertheless, there is considerable room for improvement in the treatment